logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2015.12.16 2013가합522263
손해배상(의)
Text

1. The defendant's successor's motion to intervene in the succession of the insurance company shall be dismissed;

2. The plaintiffs.

Reasons

1. Basic facts

A. The relationship between the plaintiffs and the defendants 1) The plaintiff A is the defendant medical corporation E (hereinafter "the defendant foundation").

) H Hospital operated by the H Hospital (hereinafter referred to as “Defendant Hospital”);

2) In the case of the instant operation, the instant operation shall be deemed to have been carried out in the United States, the United States, the United Nations, the fladic vertec

(2) The Defendant Foundation is the managing body of the H hospital, Defendant F is the representative director of the Defendant hospital, and Defendant G is the director of the NG as a medical specialist belonging to the Defendant hospital, and the director of the NG is the director of the NG, and the director of the NG is the director of the NG, who is a medical specialist belonging to the Defendant hospital.

B. On July 7, 2012, Plaintiff A entered the Defendant Hospital on the left side of the instant surgery, on the grounds of sporadic paralysis and pain, etc., and the inconvenience of walking therefrom. Medical personnel at Defendant G et al. conducted the Defendant Hospital’s test against Plaintiff A, etc. (2) The medical personnel at Defendant G et al., including Defendant G, diagnosed Plaintiff A’s symptoms as an escape certificate between Defendant G No. 5,00,000 and No. 1, and carried out the instant surgery against Plaintiff A on the same day. Plaintiff A discharged the Defendant Hospital on the same day on July 10, 2012 following the instant surgery.

3) On July 16, 2012, Plaintiff A re-entered the Defendant hospital by appealing for the pass of the operation department, the Defendant Hospital’s medical personnel including Defendant G, etc., and upon confirmation of the increase in the C Response margin value to 6.62mg/dl (the normal range 0.30mg/dl) as a result of the blood examination conducted by Plaintiff A, the medical personnel at the Defendant hospital including Defendant G, etc., conducted the administration and progress observation of anti-biotics, after hospitalized Plaintiff A., and continued to observe the anti-biologicals. 4) on July 23, 2012.

5..

arrow